Correction: Fecal calprotectin concentration to assess endoscopic and histologic remission in patients with cancer with immune-mediated diarrhea and colitis

Correction: Fecal calprotectin concentration to assess endoscopic and histologic remission in patients with cancer with immune-mediated diarrhea and colitis

Bibliographic Details
Main Author:	Dimitrios C Ziogas
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2021-03-01
Series:	Journal for ImmunoTherapy of Cancer
Online Access:	https://jitc.bmj.com/content/9/3/1.full

Similar Items

Fecal calprotectin concentration to assess endoscopic and histologic remission in patients with cancer with immune-mediated diarrhea and colitis
by: Jennifer Wang, et al.
Published: (2021-01-01)

Fecal calprotectin is an early predictor of endoscopic response and histologic remission after the start of vedolizumab in inflammatory bowel disease
by: Renske W. M. Pauwels, et al.
Published: (2020-12-01)

Beyond histological remission: the role of mucosal calprotectin as a potential predictor of outcomes in ulcerative colitis.
by: Guirgis, M, et al.
Published: (2016)

Can fecal calprotectin accurately identify histological activity of ulcerative colitis? A meta-analysis
by: Xiaoqi Ye, et al.
Published: (2021-02-01)

Analysis of Endoscopic Evaluation Reliability for Ulcerative Colitis in Histological Remission
by: Mimari Kanazawa, et al.
Published: (2021-10-01)

Usefulness of fecal immunochemical test and fecal calprotectin for detection of active ulcerative colitis
by: Dong Ju Kim, et al.
Published: (2018-10-01)

Fecal Calprotectin Concentrations in Cats with Chronic Enteropathies
by: Denise S. Riggers, et al.
Published: (2023-06-01)

Fecal calprotectin concentration in neonatal necrotizing enterocolitis
by: Jung Min Yoon, et al.
Published: (2014-08-01)

Fecal calprotectin predicts complete mucosal healing and better correlates with the ulcerative colitis endoscopic index of severity than with the Mayo endoscopic subscore in patients with ulcerative colitis
by: Sun-Ho Lee, et al.
Published: (2017-10-01)

Utility of fecal calprotectin as a discriminative biomarker between ulcerative colitis and irritable bowel syndrome and its ability to be used for the assessment of the remission stage of ulcerative colitis
by: Hossam M Elsaadany, et al.
Published: (2016-01-01)

Possible Correlation between Giardia duodenalis Genotypes and Fecal Calprotectin in Children with Diarrhea
by: Hanan M Abou-Seri, et al.
Published: (2022-12-01)

Fecal calprotectin role in diagnosis of ulcerative colitis and treatment follow-up
by: Mahsa Mahdipour, et al.
Published: (2019-04-01)

Is histological remission of ulcerative colitis achievable?
by: Oleg V. Knyazev, et al.
Published: (2021-08-01)

HOW MUCH AGREEMENT IS THERE BETWEEN HISTOLOGICAL, ENDOSCOPIC AND CLINICAL ASSESSMENTS OF REMISSION IN ULCERATIVE COLITIS?
by: Thomas, S, et al.
Published: (2009)

Fecal calprotectin concentration in the differential diagnosis of bowel diseases
by: M F Osipenko, et al.
Published: (2015-02-01)

Age-Related Fecal Calprotectin Concentrations in Healthy Adults
by: Shin Young Park
Published: (2020-09-01)

Correlation between gut pathogens and fecal calprotectin levels in young children with acute diarrhea
by: Yanever Angela Lam, et al.
Published: (2014-08-01)

Correlation of fecal calprotectin and patient-reported outcome measures in patients with ulcerative colitis
by: Nagesh Kamat, et al.
Published: (2022-04-01)

Defining faecal calprotectin thresholds as a surrogate for endoscopic and histological disease activity in ulcerative colitis - a prospective analysis
by: Walsh, A, et al.
Published: (2018)

Usefulness of fecal calprotectin for the early prediction of short-term outcomes of remission-induction treatments in ulcerative colitis in comparison with two-item patient-reported outcome.
by: Takahiko Toyonaga, et al.
Published: (2017-01-01)

Association Between Fecal Calprotectin Concentration and Mesenteric Lymphadenopathy in Children
by: Mahnaz Sadeghi Shabestari, et al.
Published: (2020-04-01)

Fecal <i>Filobasidium</i> Is Associated with Clinical Remission and Endoscopic Response following Fecal Microbiota Transplantation in Mild-to-Moderate Ulcerative Colitis
by: Isabelle A. M. van Thiel, et al.
Published: (2022-03-01)

Associations between Pouchitis and Fecal Calprotectin after Restorative Proctocolectomy in Patients with Ulcerative Colitis
by: Motoi Uchino, et al.
Published: (2023-07-01)

Fecal calprotectin: a marker for clinical differentiation of microscopic colitis and irritable bowel syndrome
by: von Arnim U, et al.
Published: (2016-04-01)

Fecal calprotectin and microbiota of the gut
by: V. G. Gorokhova, et al.
Published: (2016-07-01)

Fecal Calprotectin Is Increased in Stroke
by: Shin Young Park, et al.
Published: (2021-12-01)

Fecal calprotectin concentrations in healthy children aged 1-18 months.
by: Feng Li, et al.
Published: (2015-01-01)

Fecal calprotectin is a useful marker to diagnose ulcerative colitis from irritable bowel syndrome
by: Hamid Kalantari, et al.
Published: (2015-01-01)

Experimental infectious challenge in pigs leads to elevated fecal calprotectin levels following colitis, but not enteritis
by: Jéssica A. Barbosa, et al.
Published: (2021-08-01)

Role of fecal calprotectin as a biomarker of intestinal inflammation in ulcerative colitis: a prospective study
by: Onişor Danusia, et al.
Published: (2018-07-01)

Healing of the epithelial barrier in the ileum is superior to endoscopic and histologic remission for predicting major adverse outcomes in ulcerative colitis
by: Timo Rath, et al.
Published: (2023-10-01)

Evaluation of Mucosal Healing in Ulcerative Colitis by Fecal Calprotectin vs. Fecal Immunochemical Test: A Systematic Review and Meta-analysis
by: Tingpeng Hu, et al.
Published: (2023-09-01)

Fecal calprotectin in inflammatory bowel disease
by: Walsham NE, et al.
Published: (2016-01-01)

Fecal Calprotectin in Inflammatory Bowel Disease
by: Jun Lee
Published: (2016-05-01)

EVALUATION OF HISTOLOGICAL PARAMETERS IN PATIENTS WITH CLINICAL REMISSION OF ULCERATIVE COLITIS
by: O. B. Shchukina, et al.
Published: (2014-11-01)

Real-life evaluation of histologic scores for Ulcerative Colitis in remission.
by: Christian Børde Arkteg, et al.
Published: (2021-01-01)

The prognostic value of histology in ulcerative colitis in clinical remission with mesalazine
by: Giuseppe Frieri, et al.
Published: (2017-10-01)

Faecal calprotectin is the biomarker that best distinguishes remission from different degrees of endoscopic activity in Crohn’s disease
by: Francisco Guilherme Cancela e Penna, et al.
Published: (2020-02-01)

Fecal calprotectin as an indicator in risk stratification of pouchitis following ileal pouch–anal anastomosis for ulcerative colitis
by: Rui-Bin Li, et al.
Published: (2023-12-01)

Accurate cut-offs for predicting endoscopic activity and mucosal healing in Crohn's disease with fecal calprotectin
by: Juan María Vázquez-Morón, et al.